STOCK TITAN

Arxis, Inc. (ARXS) SEC Filings

ARXS NASDAQ

Welcome to our dedicated page for Arxis SEC filings (Ticker: ARXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Arxis, Inc. filings document material-event reporting for a newly public engineered-components manufacturer. The company's 8-K disclosures identify its completed initial public offering, Nasdaq-listed Class A common stock, Delaware corporate status, capital structure and related reorganization.

The filings also describe how the Arxis Businesses were placed under Arxis as wholly owned subsidiaries and record formal disclosure areas such as material definitive agreements, registered securities, governance matters and public-company reporting obligations.

Rhea-AI Summary

Arxis, Inc. completed its initial public offering of 46,575,000 shares of Class A common stock at $28.00 per share, including 6,075,000 shares from the underwriters’ option. In a concurrent reorganization, four Arxis Businesses became wholly owned subsidiaries and their prior owners received large equity stakes in Arxis.

The company retained $1,220 million in net IPO proceeds and used approximately $746 million to repay borrowings under its Term Loan Credit Facility, with the balance designated for working capital and general corporate purposes. Following these transactions, Arcline Investment Management and its affiliates hold about 99.00% of the total voting power. Arxis also adopted amended and restated its certificate of incorporation and bylaws and entered into governance, registration rights, advisory, tax receivable, and convertible common award agreements with Arcline-related entities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Arxis, Inc. officer Jennifer H. Allen filed an initial Form 3, which is a statement of beneficial ownership for company insiders. The filing reports her status as an officer of Arxis but does not show any stock transactions, purchases, sales, or derivative positions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Arxis, Inc. director Stephen Duane Oetgen filed a Form 3, which is an initial statement of beneficial ownership for insiders. The data shows no reported transactions, zero shares bought or sold, and a neutral net buy/sell direction, with no derivative securities listed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Arxis, Inc. filed an initial Form 3 for officer Sealfon Ross Bradley. This filing identifies him as an officer of the company, with the specific title referenced in remarks. The provided data show no reportable transactions or derivative positions, reflecting only his insider status at Arxis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Arxis (ARXS) SEC filings are available on StockTitan?

StockTitan tracks 24 SEC filings for Arxis (ARXS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Arxis (ARXS)?

The most recent SEC filing for Arxis (ARXS) was filed on April 17, 2026.